GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 172   

Articles published

GSK 45.79 +0.43 (0.95%)
price chart
Stock Update: GlaxoSmithKline plc (ADR) (NYSE:GSK)
[Bloomberg] GlaxoSmithKline plc (ADR) (NYSE:GSK) is exploring an initial public offering for its Viiv Healthcare Ltd.
GlaxoSmithKline plc (ADR) Declares Quarterly Dividend of $0.61 (GSK)  sleekmoney
Related articles »  
Johnson & Johnson Joins Hands With GSK To Fight Ebola
Johnson & Johnson (JNJ) and GlaxoSmithKline plc (ADR) (GSK), two of the biggest pharmaceuticals working on an Ebola treatment, are looking to collaborate to speed up the developmental process and provide a cure to the millions threatened by the Ebola ...
Related articles »  
Morning Buzz: GlaxoSmithKline plc (ADR) (NYSE:GSK), Sunedison Inc (NYSE ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) reported Q3 earnings in which sales fell 10% but EPS exceeded estimates, and announced a cost savings plan, as revenues from its flagship respiratory drug Advair continued an extended decline.
Related articles »  
First Ebola Case Diagnosed In Mali
The epidemic has pushed pharmaceutical companies like GlaxoSmithKline plc (ADR) (GSK) and Johnson & Johnson (JNJ) to accelerate the pace of research and development of their respective preventive vaccine candidates, which could be used to protect ...
Related articles »  
Analyst Update: Alcatel Lucent SA (ADR), AT&T Inc., and GlaxoSmithKline plc ...
Analysts are weighing in today on networking firm Alcatel Lucent SA (ADR) (NYSE:ALU), telecom issue AT&T Inc. (NYSE:T), and pharmaceutical power GlaxoSmithKline plc (ADR) (NYSE:GSK). Here's a quick look at today's brokerage notes on ALU, T, and ...
Stock Upgrades & Downgrades: Alcatel Lucent (NYSE:ALU), Luxottica Group ...  Property Mentor
Related articles »  
GSK Contemplates Spinning Off HIV Business
GSK is looking into an initial public offering (IPO) for the said business. The company believes that floating minority shares of the unit in the market will allow investors to better appreciate the unit's growth.
GlaxoSmithKline plc Stock Rating Reaffirmed by Zacks (GSK)  WKRB News
Related articles »  
GSK Beats On Earnings; Share Buyback And Spin-off Compensate For ...
GlaxoSmithKline plc (ADR) (GSK) released third quarter (3Q) results for fiscal year 2014 (FY14) before market opened today.
GlaxoSmithKline plc (ADR) (NYSE:GSK) Buys Stake in Aspen Pharmacare's ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) the U.K.'s biggest drugmaker, will take a stake in the Japanese subsidiary of Aspen Pharmacare Holdings Ltd.
GlaxoSmithKline plc's "Neutral" Rating Reiterated at JPMorgan ...  Watch List News (press release)
Related articles »  
GSK Expects Delayed Production Of Ebola Vaccine
GlaxoSmithKline plc (ADR) (GSK) announced today that it might not be able to develop its Ebola vaccine in time to control the epidemic.
GSK Q3 Earnings Preview: Another Disappointing Quarter Ahead
GlaxoSmithKline plc (ADR) (GSK) will announce its financials for the third quarter of fiscal year 2014 (3QFY14) on Wednesday, October 22 before markets open.